1. Tefferi A, Patnaik MM, Pardanani A. Eosinophilia: secondary, clonal and idiopathic. Br J Haematol. 2006; 133:468–492.
Article
2. Kleinfeldt T, Nienaber CA, Kische S, Akin I, Turan RG, Körber T, Schneider H, Ince H. Cardiac manifestation of the hypereosinophilic syndrome: new insights. Clin Res Cardiol. 2010; 99:419–427.
Article
3. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003; 16:265–272.
Article
4. Salanitri GC. Endomyocardial fibrosis and intracardiac thrombus occurring in idiopathic hypereosinophilic syndrome. AJR Am J Roentgenol. 2005; 184:1432–1433.
Article
5. Parrillo JE. Heart disease and the eosinophil. N Engl J Med. 1990; 323:1560–1561.
Article
6. Sheikh J, Weller PF. Clinical overview of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007; 27:333–355.
Article
7. Lofiego C, Ferlito M, Rocchi G, Biagini E, Perugini E, Branzi A, Rapezzi C. Ventricular remodeling in Loeffler endocarditis: implications for therapeutic decision making. Eur J Heart Fail. 2005; 7:1023–1026.
Article
8. Alter P, Maisch B. Endomyocardial fibrosis in Churg-Strauss syndrome assessed by cardiac magnetic resonance imaging. Int J Cardiol. 2006; 108:112–113.
Article
9. Prunier F, Delépine S, Victor J, de Gentile L, Moreau C, Laporte J, Dupuis JM, Geslin P. [Loffler's fibroblastic endocarditis. A report of a case complicating toxocarosis]. Arch Mal Coeur Vaiss. 2001; 94:226–230.
10. Herry I, Philippe B, Hennequin C, Danel C, Lejeunne C, Meyer G. Acute life-threatening toxocaral tamponade. Chest. 1997; 112:1692–1693.
Article